Copertina

Hereditary Spherocytosis due to an SPTA1 Nonsense Mutation Coinherited With α spectrin LELY in Trans

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	María‐Angustias Molina‐Arrebola, Barbara J. Bain
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	American Journal of Hematology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Not All Hereditary Iron Overload Is Hemochromatosis: A Case of Hereditary Xerocytosis Unmasked by Blood Smear Morphology
di: María‐Angustias Molina‐Arrebola, et al.
Pubblicazione: (2025)

Hereditary Elliptocytosis Resulting From Heterozygosity for β Spectrin Tandil
di: María‐Angustias Molina‐Arrebola, et al.
Pubblicazione: (2025)

MDS / MPN With SF3B1 Mutation and Thrombocytosis but Without Ring Sideroblasts
di: Biswadip Hazarika, et al.
Pubblicazione: (2025)

Loss of Function SPTA1 Variants Causes Neonatal Liver Failure and Fetal Anemia
di: John Brewin, et al.
Pubblicazione: (2025)

The Diversity of Spiculated Erythrocytes
di: Barbara J. Bain
Pubblicazione: (2024)

The spectrum of sickle cell disease
di: Barbara J. Bain
Pubblicazione: (2024)

A Transfusion Reaction due to Anti‐ER5 in a Hyposplenic β0 Thalassemia Major Patient
di: Arun Thomas, et al.
Pubblicazione: (2025)

From the eosinophil to a novel FGFR1 fusion gene
di: Kirsteen Harper, et al.
Pubblicazione: (2024)

Circulating micromegakaryocytes in an asplenic patient with post‐polycythemia myelofibrosis
di: Albert Borg, et al.
Pubblicazione: (2024)

BCR::ABL1‐Positive Acute Myeloid Leukemia
di: Alban Canali, et al.
Pubblicazione: (2025)

A Rare Combination of High‐Affinity Hemoglobin, Non‐Transfusion‐Dependent Thalassemia (Αlpha‐Triplication and Codon 39 Mutation), and Hereditary Stomatocytosis
di: Carmina Fatigati, et al.
Pubblicazione: (2026)

Hyperparathyroidism and the Hematologist
di: Hajer Oun, et al.
Pubblicazione: (2024)

Where hematology meets rheumatology—VEXAS syndrome
di: Hajer Oun, et al.
Pubblicazione: (2024)

Accurate identification of a precursor B‐cell neoplasm
di: Abdalla Dikair, et al.
Pubblicazione: (2024)

Fulminant intravascular hemolysis resulting from Clostridium perfringens infection
di: Kyo J. P. H. Renshof, et al.
Pubblicazione: (2024)

Overview on Hereditary Spherocytosis Diagnosis
di: A. Polizzi, et al.
Pubblicazione: (2024)

Partial Nuclear Extrusion in Chronic Lymphocytic Leukemia Observed to Be an In Vitro Artefact
di: Rima Chatila, et al.
Pubblicazione: (2025)

Disease burden, management strategies, and unmet needs in α‐thalassemia due to hemoglobin H disease
di: Ashutosh Lal, et al.
Pubblicazione: (2024)

Mechanistic Consequences of Piezo1 Gain‐of‐Function Variants for Decreased Red Cell Survival in Hereditary Xerocytosis
di: Asya Makhro, et al.
Pubblicazione: (2026)

Hemophagocytic Macrophages in the Peripheral Blood of a Critically Ill Patient With COVID ‐19 and RSV Infection
di: Ashik Zala, et al.
Pubblicazione: (2026)

Clinical Experience With Venetoclax‐Based Combinations for Relapsed/Refractory or MRD ‐Positive NPM1 ‐Mutated Acute Myeloid Leukemia
di: Matteo Piccini, et al.
Pubblicazione: (2026)

Promise, Pitfalls, and Precision: Standardizing Clinical Framework for Hereditary Hemorrhagic Telangiectasia and a Call for Cost‐Conscious Innovation
di: Magdalena Lewandowska
Pubblicazione: (2025)

Real‐World Outcomes in NPM1 ‐Mutated Acute Myeloid Leukemia: The Impact of Measurable Residual Disease on Disease Relapse
di: Panagiotis Tsirigotis, et al.
Pubblicazione: (2026)

Outcomes and Patterns of Relapse of NPM1 Mutated Acute Myeloid Leukemia Treated With Venetoclax Based Therapies
di: Wei‐Ying Jen, et al.
Pubblicazione: (2025)

Classic Hairy Cell Leukemia With MAP2K1 Mutation: Diagnosis and Targeted Therapy
di: Andrea Duminuco, et al.
Pubblicazione: (2025)

The Mutational Landscape in Polycythemia Vera: Phenotype, Genotype, and Prognostic Correlates
di: Masooma S. Rana, et al.
Pubblicazione: (2025)

Mixed‐Phenotype Acute Leukemia With Mutated TP53 : Genetic Landscape, Therapeutic Response, and Outcomes
di: Wei J. Wang, et al.
Pubblicazione: (2025)

Acute Leukemias of Ambiguous Lineage With MDS‐Associated Mutations Show Similar Prognosis Compared to Acute Myeloid Leukemia With MDS‐Associated Mutations: A Study From the Bone Marrow Pathology Group
di: Timothy J. Kirtek, et al.
Pubblicazione: (2024)

Novel ADAMTS13 Mutation in a Patient With Congenital TTP Diagnosed in Pregnancy
di: William Frank Mawalla, et al.
Pubblicazione: (2025)

TP53‐Mutated Myeloid Neoplasms: 2024 Update on Diagnosis, Risk‐Stratification, and Management
di: Mithun Vinod Shah, et al.
Pubblicazione: (2025)

Impact of CSF3R Mutations on Leukemic Transformation in Severe Congenital Neutropenia: A Retrospective Analysis From the Italian Neutropenia Registry
di: Francesco Pegoraro, et al.
Pubblicazione: (2026)

CSF3R Mutations in Hematological Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
di: Jiaxin Cao, et al.
Pubblicazione: (2025)

Real‐World Outcomes and Treatment Patterns in Patients With Acute Myeloid Leukemia and TP53 Gene Mutation or 17p Deletion
di: Rebecca Bystrom, et al.
Pubblicazione: (2025)

A Murine Bispecific Antibody Efficiently Redirects T Cells Against Calr Mutated Stem Cells In Vivo
di: Shengen Xiong, et al.
Pubblicazione: (2026)

TP53 Mutations Detected by NGS Are a Major Clinical Risk Factor for Stratifying Mantle Cell Lymphoma
di: Grégory Lazarian, et al.
Pubblicazione: (2025)

Intensive Chemotherapy With or Without Midostaurin in Adults ≥ 60 Years Old With FLT3 ‐Mutated AML : A FILO ‐ DATAML ‐ PETHEMA Real‐World Study
di: Gaspar Aspas Requena, et al.
Pubblicazione: (2026)

Prevalence of BTK and PLCG2 Mutations in CLL Patients With Disease Progression on BTK Inhibitor Therapy: A Meta‐Analysis
di: Stefano Molica, et al.
Pubblicazione: (2024)

Multihit TP53 Mutations in Myeloproliferative Neoplasms and Acute Myeloid Leukemia: Comparative Analysis of Survival and Risk Factors in 142 Informative Cases
di: Saubia Fathima, et al.
Pubblicazione: (2025)

Autosomal Dominant Erythrocytosis Caused by Non‐Renal Erythropoietin ( EPO ) Due to EPO c .‐136 G>A Germline Mutation
di: Lucie Lanikova, et al.
Pubblicazione: (2026)

Mutation Profiling, Efficacy Monitoring, and Prognosis Evaluation Using Circulating Tumor DNA in Peripheral T ‐Cell Lymphoma: A Prospective, Multicenter, Observational Study
di: Zhao Donglu, et al.
Pubblicazione: (2026)